Study highlights need for early detection and timely treatment of ATTR-CM
Early recognition of ATTR-CM and the timely initiation of treatment can help secure better patient outcomes.
Early recognition of ATTR-CM and the timely initiation of treatment can help secure better patient outcomes.
Patisiran led to improved functional status and quality of life among patients with ATTR-CM.
Deciding to pursue one of these therapies should be a decision made between you and your doctor.
Cardiac magnetic resonance imaging is valuable even in patients with amyloidosis without obvious heart disease.
Financial distress remains a significant problem in cases of rare diseases such as ATTR-CM.
Patients undergoing spinal decompression surgery were commonly found to have abnormal spinal amyloid deposits.
Diagnostic delays remain a significant stumbling block in the management of ATTR-CM.
Don’t be afraid to ask the hard questions; your doctor is here to help you navigate this disease.
SLGT2is improved long-term outcomes in patients with ATTR-CM, a literature review found.
Patients with a combination of ATTR-CM and aortic stenosis had worse clinical outcomes compared with those with aortic stenosis alone.